Delve into Functional Insights from Quell’s Treg Therapy to Advance Liver Transplant Outcomes

• Discover how Quell’s therapy controls immune responses to protect donor liver function
• Gain translational insights from liver biopsy data demonstrating therapeutic impact
• Understand how additional immune responses can be integrated to enhance transplant success
• Exploring allogenic therapies and rheumatoid treatments in the future of Quell Therapeutics

Speakers:

Marc Martinez-Llordella

Co-founder and Vice President Biology

Quell Therapeutics